Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-17 @ 8:47 PM
Study NCT ID:
NCT02420795
Status:
TERMINATED
Last Update Posted:
2022-04-04
First Post:
2015-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Central Nervous System Lymphoma | View |
| None | Gastric Mantle Cell Lymphoma | View |
| None | Recurrent Mantle Cell Lymphoma | View |
| None | Recurrent Non-Hodgkin Lymphoma | View |
| None | Refractory Mantle Cell Lymphoma | View |
| None | Refractory Non-Hodgkin Lymphoma | View |
| None | Splenic Mantle Cell Lymphoma | View |
Keywords: